Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease

被引：0
|
作者：
Morales, Ahmed
Salguti, Sandhya
Miao, Chuan L.
Lewis, James D.
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A211 / A211
页数：1
相关论文
共 50 条
  • [11] Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine
    Thomas, CW
    Lowry, PW
    Franklin, CL
    Weaver, AL
    Myhre, GM
    Mays, DC
    Tremaine, WJ
    Lipsky, JJ
    Sandborn, WJ
    INFLAMMATORY BOWEL DISEASES, 2003, 9 (04) : 237 - 245
  • [12] 6-mercaptopurine metabolite levels in patients with inflammatory bowel disease
    Foster, EN
    Scott, BA
    Dhawan, D
    Sheikh, RA
    Prindiville, T
    GASTROENTEROLOGY, 2002, 122 (04) : A220 - A221
  • [13] Association between 6-thioguanine nucleotide levels and preventing production of antibodies to infliximab in patients with inflammatory bowel disease
    Phillips, Jennifer
    Leary, Sam
    Tyrrell-Price, Jonathan
    BMJ OPEN GASTROENTEROLOGY, 2023, 10 (01):
  • [14] Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease
    Andoh, Akira
    Tsujikawa, Tomoyuki
    Ban, Hiromitsu
    Hashimoto, Takayoshi
    Bamba, Shigeki
    Ogawa, Atsuhiro
    Sasaki, Masaya
    Saito, Yasuharu
    Fujiyama, Yoshihide
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (09) : 1373 - 1377
  • [15] ASSAY OF 6-THIOGUANINE NUCLEOTIDE, A MAJOR METABOLITE OF AZATHIOPRINE, 6-MERCAPTOPURINE AND 6-THIOGUANINE, IN HUMAN RED-BLOOD-CELLS
    LENNARD, L
    MADDOCKS, JL
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (01) : 15 - 18
  • [16] 5-Aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine
    Hande, S
    Wilson-Rich, N
    Bousvaros, A
    Zholudev, A
    Maurer, R
    Banks, P
    Makrauer, F
    Reddy, S
    Burakoff, R
    Friedman, S
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (04) : 251 - 257
  • [17] Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease
    Derijks, LJJ
    Gilissen, LPL
    Engels, LGJB
    Bos, LP
    Bus, PJ
    Lohman, JJHM
    van Deventer, SJH
    Hommes, DW
    Hooymans, PM
    THERAPEUTIC DRUG MONITORING, 2006, 28 (01) : 45 - 50
  • [18] 6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
    Yu, Natalie
    Lee, Tanya
    Tassone, Daniel
    Vogrin, Sara
    Phan, Steven
    Wu, Damien M.
    Zhang, Jason
    Wang, Luke
    Tjahyadi, Jason
    Dutt, Krishneel
    Liou, Hana
    Basnayake, Chamara
    Wright, Emily
    Niewiadomski, Ola
    Lust, Mark
    Schulberg, Julien
    Kamm, Michael A.
    Connell, William
    Thompson, Alexander J.
    Hilmi, Ida
    Ali, Raja A. Raja
    Wei, Shu C.
    De Cruz, Peter
    Friedman, Antony B.
    Moore, Gregory T.
    Van Langenberg, Daniel
    Ding, Nik S.
    INTERNAL MEDICINE JOURNAL, 2024, 54 (11) : 1856 - 1866
  • [19] 6-Mercaptopurine and inflammatory bowel disease
    Madrigal, EJD
    Garcia, LY
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1996, 88 (06) : 455 - 456
  • [20] The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease
    Goldenberg, BA
    Rawsthorne, P
    Bernstein, CN
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (09): : 1744 - 1748
12345